Viral hepatitis associated hepatocellular carcinoma outcomes with yttrium-90 radioembolization | Zendy

Jessica M. Frakes | Zendy; Y.A. Abuodeh | Zendy; A.O. Naghavi | Zendy; M. Echevarria | Zendy; Ravi Shridhar | Zendy; Mark Friedman | Zendy; Richard D. Kim | Zendy; Ghassan ElHaddad | Zendy; Béla Kis | Zendy; B. Biebel | Zendy; Jennifer Sweeney | Zendy; Junsung Choi | Zendy; Daniel Anaya | Zendy; Anna R. Giuliano | Zendy; Sarah E. Hoffe | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Viral hepatitis associated hepatocellular carcinoma outcomes with yttrium-90 radioembolization

Author(s) -

Jessica M. Frakes,

Y.A. Abuodeh,

A.O. Naghavi,

M. Echevarria,

Ravi Shridhar,

Mark Friedman,

Richard D. Kim,

Ghassan ElHaddad,

Béla Kis,

B. Biebel,

Jennifer Sweeney,

Junsung Choi,

Daniel Anaya,

Anna R. Giuliano,

Sarah E. Hoffe

Publication year - 2018

Publication title -

journal of gastrointestinal oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.084

H-Index - 39

eISSN - 2219-679X

pISSN - 2078-6891

DOI - 10.21037/jgo.2018.03.04

Subject(s) - medicine , hepatocellular carcinoma , gastroenterology , portal vein thrombosis , proportional hazards model , hazard ratio , viral hepatitis , hepatitis c , liver disease , hepatitis b , bilirubin , cirrhosis , confidence interval

Viral associated (VA) malignancies have recently been correlated with improved outcomes. We sought to evaluate outcomes of patients with hepatocellular carcinoma (HCC) with and without viral hepatitis (hepatitis B and C) treated with lobar yttrium-90 radioembolization (Y-90 RE).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research